Ashby M - Search Results

1

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Tiong IS, Hiwase DK, Abro E, Bajel A, Palfreyman E, Beligaswatte A, Reynolds J, Anstee N, Nguyen T, Loo S, Chua CC, Ashby M, Wiltshire KM, Fleming S, Fong CY, Teh TC, Blombery P, Dillon R, Ivey A, Wei AH. Tiong IS, et al. Among authors: ashby m. J Clin Oncol. 2024 Jun 20;42(18):2161-2173. doi: 10.1200/JCO.23.01599. Epub 2024 Mar 1. J Clin Oncol. 2024. PMID: 38427924 Free PMC article. Clinical Trial.

2

Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.

Ong DM, Ashby M, Grigg A, Gard G, Ng ZY, Huang HE, Chong YS, Cheah CY, Devitt B, Chong G, Loh Z, Mo A, Hawkes EA. Ong DM, et al. Among authors: ashby m. Br J Haematol. 2019 Oct;187(1):73-81. doi: 10.1111/bjh.16049. Epub 2019 Jun 17. Br J Haematol. 2019. PMID: 31206608 Free article.

3

Allogeneic stem cell transplantation as a risk factor for recurrent melanoma.

Stevens H, Raj K, Ashby M, Grigg A. Stevens H, et al. Among authors: ashby m. Leuk Lymphoma. 2018 Jul;59(7):1750-1752. doi: 10.1080/10428194.2017.1393670. Epub 2017 Oct 31. Leuk Lymphoma. 2018. PMID: 29087220 No abstract available.

4

Artificial hydration and alimentation at the end of life: a reply to Craig.

Ashby M, Stoffell B. Ashby M, et al. J Med Ethics. 1995 Jun;21(3):135-40. doi: 10.1136/jme.21.3.135. J Med Ethics. 1995. PMID: 7674277 Free PMC article. Review.

5

Attitudes to some aspects of death and dying, living wills and substituted health care decision-making in South Australia: public opinion survey for a parliamentary select committee.

Ashby M, Wakefield M. Ashby M, et al. Palliat Med. 1993;7(4):273-82. doi: 10.1177/026921639300700403. Palliat Med. 1993. PMID: 8261193

6

Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine.

Wood MM, Ashby MA, Somogyi AA, Fleming BG. Wood MM, et al. Among authors: ashby ma. J Pain Symptom Manage. 1998 Aug;16(2):112-20. doi: 10.1016/s0885-3924(98)00043-8. J Pain Symptom Manage. 1998. PMID: 9737102 Free article. Clinical Trial.

7

Opioid substitution to reduce adverse effects in cancer pain management.

Ashby MA, Martin P, Jackson KA. Ashby MA, et al. Med J Aust. 1999 Jan 18;170(2):68-71. doi: 10.5694/j.1326-5377.1999.tb126885.x. Med J Aust. 1999. PMID: 10026686

8

"Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients.

Jackson K, Ashby M, Martin P, Pisasale M, Brumley D, Hayes B. Jackson K, et al. Among authors: ashby m. J Pain Symptom Manage. 2001 Oct;22(4):834-42. doi: 10.1016/s0885-3924(01)00340-2. J Pain Symptom Manage. 2001. PMID: 11576800 Free article.

9

Opioids in palliative care: emerging clinical trends.

Ashby M, Jackson K. Ashby M, et al. Intern Med J. 2003 Jul;33(7):265-6. doi: 10.1046/j.1445-5994.2003.00408.x. Intern Med J. 2003. PMID: 12823669 No abstract available.

10

Ketamine and cancer pain: the reports of my death have been greatly exaggerated.

Jackson K, Franco M, William L, Poon P, Pisasale M, Kenner D, Brumley D, Mewett G, Ashby M, Viney M, Kerr D. Jackson K, et al. Among authors: ashby m. J Clin Oncol. 2013 Apr 1;31(10):1373-4. doi: 10.1200/JCO.2012.47.1235. Epub 2013 Feb 19. J Clin Oncol. 2013. PMID: 23423743 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters